Gastroesophageal reflux disease (GERD) characterized by heartburn and/or regurgitation
symptoms is one of the most common gastrointestinal disorders managed by …

Background The efficacy of transoral incisionless fundoplication (TIF) performed with the
EsophyX device (Redmond, Washington, USA) and its long-term outcomes in …

Background The incidence of proton pump inhibitor (PPI)-refractory gastroesophageal reflux
disease (GERD) has been increasing. While surgical intervention with Laparoscopic Nissen …

Background The efficacy and safety of magnetic sphincter augmentation (MSA) with the
LINX device (Torax Medical) has been reported in several short-and long-term studies …

Background The majority of endoscopic antireflux procedures for GERD are cumbersome to
use and randomised long-term data are sparse. We conducted such a trial to determine the …

Gastroesophageal reflux disease (GERD) has consistently been the most frequently
diagnosed gastrointestinal malady in the USA. The mainstay of therapy has traditionally …

Up to 40% of patients report persistent gastroesophageal reflux disease (GERD) symptoms
despite proton pump inhibitor (PPI) therapy. This review outlines the evidence for medical …

Gastroesophageal reflux disease (GERD) is a frequently encountered disorder. Obesity is
an important risk factor for GERD, and there are several pathophysiologic mechanisms …

Gastroesophageal reflux disease has an increasing incidence and prevalence worldwide. A
significant proportion of patients have a suboptimal response to proton pump inhibitors or …

Background Given poor symptomatic response rates and rising awareness of the adverse
events associated with the long-term use of proton pump inhibitors (PPIs), endoscopic …